NCT02000089 2025-10-09
CAPS5
Johns Hopkins University
Phase 3 Recruiting
Clinical Trials
9 trialsNCT03404661 2023-06-06
Optical and Biochemical Biomarkers in Early Pancreatic Cancer
Mayo Clinic
Completed
NCT01371240 2022-06-16
Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity
University Hospitals Cleveland Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT00438906 2021-06-18
CAPS 3
Johns Hopkins University
Completed
NCT01094561 2016-09-09
Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients
Columbia University
Phase NA Completed
NCT01094626 2016-06-10
Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection
Columbia University
Phase NA Withdrawn
NCT01094535 2015-04-06
Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery
Columbia University
Phase NA Withdrawn
NCT00587132 2013-06-24
Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma
Mayo Clinic
Phase 1/2 Terminated
NCT01094600 2012-07-02
Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency
Columbia University
Phase NA Withdrawn